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Purpose: Mutations of the FERM domain containing protein 7 gene (FRMD7) are associated with X-linked idiopathic
congenital nystagmus. Previous studies have shown that FRMD7 plays an important role in neuronal development and is
involved in the regulation of F-actin. However, its specific mechanism of action remains undetermined.
Methods:  Our  study  used  quantitative  real-time  PCR  to  assess  the  levels  of  neuron-specific  genes  in  a  mouse
neuroblastoma cell line (Neuro-2a) after transfection with a full-length coding transcript of FRMD7 or a blank control
vector. F-actin was detected by rhodamine-phalloidin staining. Neurite number and length were assessed by a confocal
laser scanning microscope.
Results: We demonstrated that FRMD7 can promote neurite outgrowth following retinoic acid–induced differentiation
in Neuro-2a cells. Neurites were significantly longer in cells transfected with FRMD7, but there was no difference in cell
numbers.  The  mRNA  expression  of  neuron  cytoskeletal-related  genes  (microtubule-associated  protein  2  [Mtap2],
neurofilament-L and M [NF-L and  NF-M] and the microtubule-associated protein tau [MAPT]) were significantly
increased compared to controls. Other genes (NF-H, MAPT, neuron-specific class III beta-tubulin (Tuj-1), nestin, and
growth-associated protein-43 [GAP-43]) were not obviously altered by FRMD7 overexpression.
Conclusions: Taken together, our data suggest that FRMD7 promotes the extension of neurites and may be involved in
regulating the movement of cytoskeletal proteins, which influences not only F-actin, but also NF and microtubule
dynamics.
Idiopathic congenital nystagmus (ICN) is an oculomotor
disorder that arises from a primary defect in the brain regions
involved in ocular motor control. ICN is characterized by
involuntary horizontal oscillations of both eyes, and its onset
occurs  within  six  months  of  birth  [1].  Patients  with  ICN
experience a significant decrease in their quality of life over
their lifetime. The prevalence of the disorder is estimated to
be 24 per 10,000; pharmacological agents such as memantine
and gabapentin have been shown to be effective for congenital
nystagmus [2,3].
Mutations of the FERM domain containing protein 7
(FRMD7) gene are known to be one of the main causes of X-
linked idiopathic congenital nystagmus. To date, more than
40 mutations of FRMD7 have been reported from various
ethnic backgrounds [4-9]. Previous studies have shown that
downregulation of the expression level of FRMD7 leads to a
significant reduction in the length of neurites during retinoic
acid  (RA)-induced  differentiation  in  Neuro-2a  cells.
Meanwhile, a notable disturbance in the dynamics of F-actin
and F-actin/G-actin has been observed when FRMD7 was
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knocked down in Neuro-2a cells [10]. Previous studies have
shown that COOH-terminal truncated mutations alter their
subcellular localization and lead to no longer co-localization
with F-actin like the wild type FRMD7 [11]. This evidence
suggests a critical role of FRMD7 in neurite outgrowth, which
may be at least in part associated with the dynamics of F-actin.
However, whether FRMD7 can directly trigger the initiation
of  neurite  extension  has  not  been  elucidated.  The  precise
biochemical  role  of  FRMD7  in  neuronal  development,
especially  its  involvement  in  ICN  pathogenesis,  remains
unclear.
In vivo, soon after migrating to their final destination,
neurons begin to form neurites. These neurites eventually
differentiate to develop axons and dendrites [12]. Neuro-2a
neuroblastoma cells have been widely used as an in vitro
neuronal differentiation model that closely mimics the events
that occur during neuronal development by incubation with
RA [13,14]. RA-induced Neuro-2a cell differentiation leads
to  the  expression  of  neurite-bearing  and  neuron-specific
proteins, such as microtubule-associated protein 2 (Mtap2)
and neuron-specific nuclear protein (NeuN), among others,
which results in the development of neuron-like cells. An
understanding  of  these  neuron-specific  genes,  especially
cytoskeletal-related  genes,  and  the  modification  of  their
expression  induced  by  the  consequent  overexpression  of
FRMD7 in Neuro-2a cells, may reveal a novel link between
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1428FRMD7  and  neuronal  outgrowth.  In  this  study,  we
investigated neurite outgrowth and the expression levels of
some neuron-specific proteins following overexpression of
the protein FRMD7 in Neuro-2a cells.
METHODS
Animals: The mice we used were purchased from the Animal
Center  of  Zhejiang  University  School  of  Medicine
(Hangzhou,  China).  All  experimental  procedures  were
approved  by  the  institutional  committee  at  Zhejiang
University.
Ribonucleic  acid  isolation  and  reverse  transcription–
polymerase chain reaction: Total RNAs were isolated using
TRIZOL reagent (Invitrogen, San Diego, CA) according to
the  manufacturer’s  instructions  from  18-day  embryonic
mouse  brains  and  Neuro-2a  cells  had  previously  been
transfected with mFRMD7-pcDNA3.1(+) or pcDNA3.1(+)
plasmids which were performed as follows (in the plasmid
construction section). RNA (5 µg) was reverse transcribed
using oligo dT by reverse transcriptase. Briefly, cells and
tissues grounded to powder in liquid nitrogen were added the
TRIZOL reagent to dissociation of nucleoprotein complexes.
The Chloroform was used to separate the RNA exclusively in
the aqueous phase. RNA was precipitated by Ethanol. RNA
(5 μg) was reverse transcribed using oligo dT by reverse
transcriptase. For PCR amplification, specific oligonucleotide
primer pairs (10 pmol each) were incubated with 2 µl cDNA
template in 25 µl PCR reaction mixtures containing 1.5 mM
MgSO4, mixed deoxynucleotides (1 mM each), and 0.5 U
KOD FX PLUS (Toyobo, Osaka, Japan) polymerase. The
sequences of primers used were as follows: mouse FRMD7
sense primer, 5'-ATG CTC CAT TTA AAA GTG-3' and
antisense  primer,  5'-AGG  CTA  AGA  AAT  AAT  TGC-3'
(product  length,  2,112  bp).  Dilutions  of  the  cDNAs  were
amplified for 38 cycles at 94 °C for 2 min, 98 °C for 15 s,
60 °C for 45 s, and 68 °C for 2 min 20 s. The amplified PCR
products were analyzed by 1.2% agarose gel electrophoresis
and ethidium bromide staining.
Plasmid construction: The PCR products were confirmed by
subcloning  the  amplified  cDNAs  into  the  pGEM-T  Easy
Vector  System  (Promega,  Madison,  WI)  for  sequencing.
Mouse FRMD7 cDNA, was digested with XhoI and BamHI,
and fused to enhanced green fluorescent protein (EGFP) in
pEGFP-N1  (Invitrogen,  Carlsbad,  CA).  The  cDNA  was
digested  with  BamHI  and  XhoI,  and  subcloned  into
pcDNA3.1(+) vector (Invitrogen).
Cell  culture,  transient  transfection,  and  differentiation:
Mouse neuroblastoma cells (Neuro-2a) were purchased from
the Chinese Academy of Sciences Committee Type Culture
Collection Cell Bank/CAS Shanghai Institutes for Biologic
Sciences Cell Resource Center (Shanghai, China). Neuro-2a
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM;  Invitrogen)  containing  10%  fetal  bovine  serum
(FBS;  Invitrogen),  and  10%  penicillin  and  streptomycin.
Cultures were maintained in 5% CO2 at 37 °C, and were
passaged every 2–3 days. For differentiation experiments,
cells were grown on chamber slides to 40%–50% conﬂuence
in 24 well plates, then transfected with 0.4 µg plasmid DNA
(mFRMD7-EGFP-n1 or pEGFP-n1) and 1.5 µl Attractene
Transfection Reagent (Qiagen, Valencia, CA) per well. After
6 h, cells were rinsed and fresh DMEM (containing 10% FBS)
was added. Twenty-four hours later, cells were subjected to
RA (Sigma-Aldrich, St Louis, MO) treatment (10 µM RA in
2% FBS/DMEM).
Western blotting, immunofluorescence, and F-actin staining:
For  western  blots,  cultured  cells  were  homogenized  in
radioimmunoprecipitation  assay  buffer  with  1×  protease
inhibitor  cocktail  (Sigma-Aldrich)  and  100  mg/ml  of
phenylmethylsulfonyl  fluoride.  Equal  amounts  of  protein
were separated by sodium dodecyl sulfate PAGE (8% gels)
and transferred to a polyvinylidene fluoride membrane (Bio-
Rad,  Hercules,  CA).  After  blocking  with  5%  skim  milk
powder, membranes were incubated with the primary mouse
anti-flag antibody (Sigma–Aldrich) at 1:4,000 dilution, and
the  membrane-bound  antibody  was  visualized  with
horseradish  peroxidase–conjugated  secondary  antibody
(Abmart, Shanghai, China), diluted 1:5,000. The membranes
were  processed  using  the  ECL  advance  western  blotting
detection kit (Qiagen). β-actin (Santa Cruz, CA) was used as
a loading control.
Three days after RA treatment, cells were fixed in 4%
formaldehyde in PBS (50 mM NaPO4, 150 mM NaCl, pH 7.4)
for 15 min at room temperature (RT). F-actin was stained
using  TRITC-conjugated  rhodamine-phalloidin  (77481;
Sigma-Aldrich) fluorescein diluted with PBS and BSA for 45
min at RT. After washing in PBS, cell nuclei were stained with
4',6-diamidino-2-phenylindole (1:5,000 dilution; ZhongShan
Goldenbridge Biotechnology Co. Ltd., Beijing, China) for 5
TABLE 1. NEURITE OUTGROWTH OF NEURO-2A CELLS TREATED WITH 10 UM RETINOIC ACID.
Measure items control FRMD7
Cells with neurites (%) 38.63±3.65 41.87±3.46
Neurite length (μm) 68.99±2.59 94.40± 2.62**
        Neuro-2a cells transfected FRMD7 or not were treated with 10 μm retinoic acid, 2% FCS/DMEM for 3 days, and neurites
        parameters were quantified. Datas are mean±SEM of three independent experiments. n>250 cells counted for each experiment.
        **p<0.01 compared with the control.
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1429min at RT. Morphological features were quantified using a
confocal laser scanning microscope (Leica TCS SP5 X; Leica,
Wetzlar, Germany).
Neurite  length  measurement:  Neurite  length  measurement
was performed as described previously [15]. Neurite length
was  observed  72  h  after  RA-induced  differentiation  of
Neuro-2a cells. Images were captured on a Leica TCS SP5 X
microscope. Statistics were gathered on the percentage of cells
with neurites (a neurite is defined as an outgrowth with a
length more than half the diameter of the cell body) and
longest neurite length (neurite length from cell body to distal
tip), counted from at least five randomly taken images per
well. The data presented are the mean of three independent
experiments, shown as the mean±standard error of the mean
(SEM), with p<0.05 via Mann–Whitney U test. At least 250
cells per experiment were scored for neurite outgrowth (Table
1).
Quantitative  real-time  polymerase  chain  reaction:
Quantitative  real-time  (RT)-PCR  amplification  was
performed to assess the relative abundance of neuron-specific
genes  (microtubule-associated  protein  2  (Mtap2),  neuron-
specific  nuclear  protein  (NeuN),  neurofilament-L  (NF-L),
neurofilament-M (NF-M), neurofilament-H (NF-H), neuron-
specific  class  III  beta-tubulin  (Tuj-1),  nestin  and  growth-
associated  protein-43  (GAP-43),  microtubule-associated
protein tau (MAPT), and Nestin) mRNA (mRNA) compared
with  a  reference  gene,  glyceraldehyde-3-phosphate
dehydrogenase  (GAPDH).  Quantitative  RT–PCR  was
performed using a custom-made RT–PCR assay with SYBR
green chemistry (Toyobo) in an ABI Prism 7700 sequence
detector (Applied Biosystems, Foster City, CA). The 2-△△CT
method was used to calculate the relative ratio of neuronal
specific  genes  to  GAPDH  gene  concentrations  [16].  The
sequences of the specific primers used are provided (Table 2).
Statistical  analysis:  All  experiments  were  performed  in
triplicate for each condition, and from at least three different
cell  culture  preparations.  Results  are  expressed  as  mean
±SEM. Statistical analysis was performed by Mann–Whitney
U test or by Student t test using SPSS16.0 software (SPSS,
Inc.,  Chicago,  IL).  Levels  of  significance  were  *p<0.05,
**p<0.01, and ***p<0.001.
RESULTS
Overexpression of FRMD7 promoted neurite outgrowth in
RA-induced differentiated Neuro-2a cells: Previous studies
found that knockdown of FRMD7 led to neurite outgrowth
shortened  during  RA-induced  differentiation  in  Neuro-2a
cells [10]. However, whether FRMD7 can directly trigger the
initiation of neurite extension and overexpression of FRMD7
promotes neurite outgrowth in Neuro-2a cells has not been
TABLE 2. PRIMER SEQUENCES USED FOR REAL-TIME QUANTITATIVE RT–PCR
Gene Primer sequence Product length (bp)
Mtap2 for catcatccgcactcctccaa 148
Mtap2 rev aatcctaacctgacccccctt  
Nestin for tcaaccctcaccactctatttt 143
Nestin rev gctgttttctacttttacctctgtg  
NeuN for caccactctcttgtccgtttg 106
NeuN rev gctgctggctgagcatatct  
NF-L for gaaggcgaagagaccagg 134
NF-L rev gagcgagcagacatcaagtag  
NF-M for accgaggcagaaggtgaag 137
NF-M rev gatttgggcataggggattt  
NF-H for ctcccaaaaattccctccata 139
NF-H rev ctgtcactccttccgtcacc  
MAPT for ccctggaggagggaataagaag 135
MAPT rev aggtgccgtggagatgtgt  
Tuj-1 for acgcatctcggagcagtt 125
Tuj-1 rev cggacaccaggtcattca  
GAP-43 for ggagaagaagggtgaagggg 100
GAP-43 rev ggacggggagttatcagtgg  
GAPDH for ccttccgtgttcctacccc 132
GAPDH rev agcccaagatgcccttcag  
FRMD7 for atgcaaggctttctggaagac 111
FRMD7 rev cggaaactggaacctttgcta  
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1430Figure 1. Effects of FRMD7 overexpression on neurite outgrowth in undifferentiated or differentiated Neuro-2a cells. A, B: Neuro-2a cells
transfected with FRMD7-pEGFP-n1 (B) or the empty pEGFP-n1 vector (A) was treated with retinoic acid (RA) for 3 days. The cells were
fixed and stained with TRITC-conjugated rhodamine-phalloidin. Statistics were gathered on the percentage of cells that bore neurites and the
length of the longest outgrowing neurite from the cell bodies of the evaluated cells. FRMD7 demonstrated a remarkable potential to increase
neurite length compared with control cells. However, the number of cells with neurites was no different between groups. The overexpression
of FRMD7 without RA treatment did not change the morphology of Neuro-2a cells (data not shown). Magnification: 100x. Scale bars: 50
μm. C: The average length of the longest outgrowing neurite from differentiated Neuro-2a cells transfected with FRMD7-pEGFP-n1 (FRMD7)
or the empty pEGFP-n1 vector (CON). **p<0.01 compared with the control.
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1431elucidated. Thus, we sought to examine how overexpression
of  FRMD7  would  affect  neurite  development  in
undifferentiated or differentiated Neuro-2a cells. We showed
that overexpression of FRMD7 without RA treatment did not
alter the morphology of Neuro-2a cells (data not shown).
Conversely, cells transfected with FRMD7-EGFP-n1 showed
a  variety  of  morphological  changes  under  RA-induced
differentiated  conditions.  Data  were  gathered  on  the
percentage of cells that bore neurites that were greater than
one times the soma diameter from at least five randomly taken
images per well. Neurite length was determined by measuring
the length of the longest outgrowing neurite from the cell
bodies of the evaluated cells. FRMD7 transfection showed a
remarkable ability to increase the length of neurites compared
with the control cells under the same serum-depleted RA-
induced conditions. We observed a significant increase in
neurite  length  after  FRMD7  transfection
(control=68.99±2.59,  FRMD7=94.40±2.62,  p<0.01).
However,  the  number  of  cells  with  neurites  was  not
significantly  different  (control  38.63±3.65,  FRMD7
41.87±3.46; Figure 1 and Table 1).
FRMD7 regulated mRNA expression levels of neuron-specific
genes in Neuro-2a cells: To address the specific function of
FRMD7  in  differentiation,  we  examined  the  mRNA
expression levels of various neuron-specific genes related to
different  steps  of  neuronal  development,  including  the
Figure 2. Overexpression of FRMD7 regulated the mRNA expression levels of neuron-specific genes in Neuro-2a cells. Cells transfected with
the empty vector served as the negative control (MOCK group). The expression of Mtap2, NF-L, NF-M, and NeuN mRNA (mRNA) doubled
48 h after transfection. The expression levels of NF-L and NF-M mRNA continued to increase, reaching a 2.2-fold increase 7 days after
transfection. The mRNA levels of other genes (Nestin, NF-H, MAPT, GAP-43, and Tuj-1) did not change obviously. The data are presented
as changes relative to the MOCK group. All of the experiments were performed in triplicate, and the graph represents the average (columns,
mean; bars, SEM; *p<0.05, **p<0.01 versus MOCK group).
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1432cytoskeletal-related  genes  (Mtap2,  NF-L,  NF-M,  NF-H,
Tuj-1,  and  MAPT)  and  neuronal  differentiation  markers
(NeuN, GAP-43, and Nestin). A time-course experiment was
performed to determine the role of FRMD7 in neuron-specific
gene expression in Neuro-2a cells. Interestingly, within 48 h
of transfection with FRMD7-pcDNA3.1, which contained a
full-length cDNA encoding FRMD7, Mtap2, NF-L, NF-M,
and NeuN mRNA expression levels significantly increased
compared with the controls. The expression of Mtap2, NF-L,
NF-M, and NeuN mRNA approximately doubled 48 h after
transfection. The expression levels of NF-L and NF-M mRNA
continued to increase, reaching a 2.2 fold increase 7 days after
transfection (Figure 2). The expression levels of other genes
that were tested did not change obviously. Furthermore, the
expression levels of FRMD7 at the indicated time points in
Neuro-2a cells were confirmed by western blot (Figure 3).
Mtap2  and  neurofilaments  (NFs)  are  neuronal
cytoskeletal proteins that are expressed in mature neurons
[17,18]. The above changes suggest that FRMD7 promotes
neuronal  differentiation  and  may  be  involved  in  the
upregulation of cytoskeletal proteins, which affects not only
F-actin but also microtubule and NF dynamics.
DISCUSSION
The FRMD7 gene, which is the major etiological contributor
of ICN, is a member of the super 4.1 family of proteins, and
shares a 4.1 ezrin, radixin, moesin (FERM) domain at its N-
terminus [4]. In a previous study, a significant reduction in the
overall length of neurites was detected using RA-induced
differentiation, when FRMD7 was knocked down in Neuro-2a
cells [10]. However, it remains unclear whether FRMD7 can
trigger  the  initiation  of  neurite  extension,  and  the  precise
biochemical role of FRMD7 in neuronal development has yet
to be elucidated. To investigate the role of FRMD7 in the
initiation  of  neurite  outgrowth,  we  examined  the
differentiation of neuronal cells and neurite length when a
plasmid containing a full-length cDNA coding for FRMD7
was  transfected  into  Neuro-2a  cells.  We  found  that  the
overexpression of FRMD7 in Neuro-2a cells alone was not
sufficient  to  induce  the  extension  of  neurites.  However,
following RA-induced neuronal differentiation of Neuro-2a
cells, FRMD7 augmented neuronal formation, which resulted
in longer neurites than in the control cells. This result was
consistent with previous work [10] and further confirmed that
FRMD7 plays a critical role in the process of RA-induced
differentiation in Neuro-2a cells.
Neuro-2a is a mouse neural crest–derived cell line that
has been extensively used to study neuronal differentiation.
RA-induced neuronal differentiation in Neuro-2a cells is a
complex procedure that alters the expression levels of many
neuron-specific  proteins.  The  sequence  of  neuronal
differentiation  events,  including  the  loss  of  pluripotency,
formation of neuronal precursors and their further maturation,
were mirrored in the marker mRNA expression profiles. We
performed  a  detailed  series  of  time-lapse  studies  with  11
neuron-specific genes and their mRNA expression profiles
after FRMD7 transfection. The mRNA expression of Mtap2,
NF  genes  (NF-L  and  NF-M)  and  NeuN  were  highly
upregulated 48 h after transfection compared to control cells
(p<0.05).  Other  genes  showed  no  significant  alteration.
Expression  of  the  housekeeping  gene  GAPDH  was  not
statistically  significantly  different  (p>0.05)  between  the
different time points and treatments.
Mtap2 is a neuronal cytoskeletal protein expressed in
mature  neurons  [17],  which  can  interact  with  both
microtubules [19] and actin filaments [20,21]. Mtap2 is an
expressed  abundantly  during  all  stages  of
neuromorphogenesis  [22].  In  the  primary  hippocampal
neurons, it is first expressed in neuroblasts before neurite
initiation. It is then present in minor process that eventually
differentiates  into  an  axon.  During  later  stages  of
differentiation, Mtap2 disappears from axons but is retained
in dendrites [22]. This expression pattern suggests that Mtap2
plays a role in both early and late morphological events. As a
result,  FRMD7  may  play  an  important  role  in  neurite
outgrowth involved in influencing the dynamics of F-actin
[10,11].  Microtubules  and  F-actin  are  major  structural
components  of  the  neuronal  cytoskeleton,  and  play  an
essential role in the elaboration of axons and dendrites [20,
21,23].  Our  results  suggest  that  FRMD7  regulates  the
neuronal differentiation in relation to Mtap2.
NFs  are  neuron-specific  cytoskeletal  intermediate
filament proteins, which are assembled from three constituent
polypeptides of apparent molecular weights of 68 kDa (NF-
L), 145 kDa (NF-M), and 200 kDa (NF-H) as separated on a
sodium dodecyl sulfate PAGE. They are known to undergo
significant changes in subunit composition in both developing
and adult neurons that inﬂuence both the morphology and
physiology of axons [24,25]. NFs determine axonal caliber
Figure 3. Expression levels of FRMD7 at the indicated time points
in Neuro-2a cells were confirmed by western blot. FRMD7 was
monitored  by  western  blot  in  transfected  Neuro-2a  cells  at  the
indicated time points. Samples (cells) from cultured Neuro-2a cells
transfected with pcDNA3.1 (+)-FRMD7-flag at different time points
(24 h, 48 h, 72 h, and 7 days) were detected. The blots were probed
with the labeled antibody anti-flag. β-actin was used as an internal
control.
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1433and promote axonal growth over long distances [26,27]. The
NF-L and NF-M mRNAs are coexpressed during the early
embryonic  stages  of  neuronal  differentiation  and
development, while NF-H mRNA is expressed only at a later
embryonic and early postnatal stage [28]. The time course of
NF mRNA expression in differentiating Neuro-2a cells was
also examined. An increase in NF-L and NF-M mRNA levels
was  observed  at  early  stage  following  the  induction  of
differentiation. In contrast, the expression of NF-H mRNA
followed a very different time course, with an increase later
after differentiation [29]. FRMD7 upregulated the increase of
NF-L and NF-M mRNA levels, but not NF-H in Neuro-2a
cells, which suggests that FRMD7 promotes Neuro-2a cell
differentiation at the early stage. It may also indicate that
FRMD7  is  involved  in  neuronal  differentiation  and
development during the early stages of embryogenesis.
In  summary,  we  have  shown  that  FRMD7  promotes
neurite outgrowth and may be involved in the movement of
cytoskeletal proteins; this not only affects F-actin but also
influences both NF and microtubule dynamics.
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